Understanding And Supporting Fatty Liver And Pancreas Webinar

Since its initial identification in 1926, the role of intrapancreatic fat (IPF) in health has intrigued scientists. Recent decades, especially amid rising obesity rates, have spotlighted pancreatic steatosis' potential as a Metabolic Syndrome component. It's linked to NAFLD, insulin resistance, type 2 diabetes, and possibly pancreatic cancer, emphasizing the urgency of understanding its clinical impacts.

Current consensus highlights dietary management and weight loss as primary interventions, with ongoing research into beneficial nutrients found in supplements. This evolving field underscores the need for further exploration into pancreatic fat and its metabolic consequences.

This perspective encourages personalized dietary interventions and the strategic use of nutrients present in supplements to support weight management and improve pancreatic health, viewing IPF not just as a symptom but as a pivotal factor in the broader spectrum of metabolic syndrome.

Learning Objectives:

1. Understanding of fatty pancreas prevalence and its significance.
2. Exploration of NAFLD's link to pancreatic health.
3. Comparison of diagnostic approaches for NAFLD and pancreatic conditions.
4. Assessment of atherosclerosis risk in relation to fatty pancreas.
5. Link between the gut-pancreas-liver axis and its implications.
6. Role of incretin hormones GIP and GLP-1 in liver and pancreatic functions.
7. Connection between gut microbiota dysbiosis and its impact on the Gut-Liver-Pancreas Axis in NAFLD.
8. Identification and application of antioxidants beneficial for pancreatitis.
9. Discovery and understanding of supplement ingredients effective against fatty liver and pancreas.

The webinar recording lasts 66 minutes, including a Q & A session.